Cartilage Tissue Engineering

Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age30-70
SponsorChin-Hung Chang

About this trial

In this study, the investigators explored the hypothesis that osteoarthritic cartilage fragments can promote chondrogenesis of MSCs. Non-wearing parts of cartilage tissues were harvested from one osteoarthritic patient during the total knee arthroplasty surgery. Cartilage fragments and MSCs were wrapped into fibrin glue; and the constructs were implanted subcutaneously into nude mice.

Moreover, the investigators will collect the discard cartilage to develop an acellular cartilage ECM-derived scaffold in the joint replacement surgery. In addition, the investigators will harvest the redundant bone marrow from drilling or useless synovium during the surgery to separate the mesenchymal stem cells. Furthermore, these mesenchymal stem cells will be transfected with hTERT for rejuvenation and then will be labeled with fluorescent dye PKH26 for application of animal study. To sum up, the investigators plan to use human, natural, and discard materials from the joint replacement surgery to develop appropriate allograft for cartilage repair and hope that one day this ideal would be apply in clinical.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

30-70 years old

Disqualifiers

more than 70 years old

Trial design

Treatments tested in this trial

  • total knee / hip replacement

    Other intervention

    Human cartilage tissues were harvested from osteoarthritic patient during total knee arthroplasty surgery.

Treatment groups

No treatment groups listed

Trial outcomes

This trial has no outcomes listed.

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chin-Hung Chang

Lead sponsor

Far Eastern Memorial Hospital

Sponsor institution